Thytech
THYTECH is a spin-off of the Gregorio Marañón Health Research Institute (IISGM) that was created with the aim of transferring to the patient our patented technology for the treatment of diseases related to immune disorders.
Thytech has raised €350k across 1 funding round from 1 investor, most recently a round in Apr 2022. Based in Madrid, Spain; active in Healthtech. Data as of 28 Oct 2026.
Madrid, Spainwww.inmunoregulacion.es ↗
Total raised
€350k
€350,000
Funding rounds
1
Investors
1
distinct backers
Active since
2022-04
latest 2022-04
Funding by year
EUR raised per yearThytech — funding by year — interactive chart.
Data table
| Thytech — funding by year | |
|---|---|
| 2022 | €350k |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-08 | Other | €350k | Banco Sabadell's BStartup | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData